Ascendis Pharma Ratios and Metrics

Market cap in millions BRL. Fiscal year is January - December.

Millions BRL. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	79,600	67,297	41,950	36,273	34,790	37,522
Market Cap Growth	-	60.42%	15.65%	4.26%	-7.28%	-17.80%
Enterprise Value	81,500	68,824	43,524	37,651	33,550	34,180
PS Ratio	15.29	15.64	21.77	24.16	124.47	833.13
PB Ratio	27.12	-69.18	-74.90	-44.23	24.19	7.33
P/TBV Ratio	11.92	-	-	-	26.49	8.39
P/FCF Ratio	294.12	209.00	-	-	-	-
P/OCF Ratio	218.78	209.00	-	-	-	-
EV/Sales Ratio	16.04	16.00	22.59	25.08	120.03	758.93
EV/FCF Ratio	301.14	213.74	-	-	-	-
Debt / Equity Ratio	0.79	-2.37	-3.45	-1.53	1.83	0.11
Debt / FCF Ratio	14.82	16.18	-	-	-	-
Net Debt / Equity Ratio	0.66	-1.57	-2.81	-1.68	-0.86	-0.65
Net Debt / EBITDA Ratio	-107.02	-2.16	-1.14	-0.56	0.42	1.32
Net Debt / FCF Ratio	5.35	4.75	-0.97	-0.52	0.46	1.31
Asset Turnover	0.52	0.58	0.36	0.28	0.05	0.01
Inventory Turnover	0.10	-0.32	-0.18	0.26	-0.12	-0.09
Quick Ratio	0.68	0.72	0.81	0.62	4.44	7.03
Current Ratio	1.00	1.04	1.17	0.95	5.39	8.03
Return on Equity (ROE)	305.05%	169.84%	300.78%	-818.43%	-101.69%	-44.54%
Return on Assets (ROA)	1.30%	-11.77%	-28.17%	-48.30%	-52.15%	-43.72%
Return on Invested Capital (ROIC)	4.11%	-57.89%	-156.57%	-738.04%	-330.83%	-174.13%
Return on Capital Employed (ROCE)	-1.31%	-53.99%	-154.56%	-90.43%	-59.04%	-47.27%
FCF Yield	0.34%	0.48%	-	-	-	-
Buyback Yield / Dilution	-5.21%	-4.69%	-2.85%	-0.38%	-2.37%	-8.21%
Total Shareholder Return	-5.21%	-4.69%	-2.85%	-0.38%	-2.37%	-8.21%